Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 27 Nov 2024 | Laurent Muschel Acting Director-General | Pipeline & production facilities | — |
| 27 Nov 2024 | Laurent Muschel Acting Director-General | Pipeline & production facilities | SRC |
Mission & Goals
Cepheid is an automated molecular diagnostics innovator, focused on the speed and accuracy of PCR testing, enabling a higher quality of care, lower costs, and improved outcomes. Cepheid is a key player in point of care testing (POCT) for multiple clinical applications including COVID-19, healthcare-associated infections (HAIs), sexual health, critical infectious disease, virology, and oncology. The European headquarters are located in Maurens-Scopont, France, with the manufacturing site based in Solna, Sweden.
EU Legislative Interests
Health Technology Assessment, In-Vitro Diagnostic / Medical Devices Regulations, Shaping Europe’s Digital Strategy, Horizon Europe, Green Deal, Supply Shortages, Cross-border Healthcare, European Health Union, HERA, EU4Health, Europe’s Beating Cancer Plan, COVID-19 pandemic, Pandemic Response Preparedness.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Danaher Corporation www.danaher.com
Organisation Members
Cepheid is a member of MedTech Europe www.medtecheurope.org and national in vitro diagnostics associations.